Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness... see more

NDAQ:INM - Post Discussion

InMed Pharmaceuticals Inc > Q3 Report - 13 May
View:
Post by Bullknit101 on May 06, 2021 9:49pm

Q3 Report - 13 May

https://finance.yahoo.com/news/inmed-pharmaceuticals-report-third-quarter-113000029.html
Comment by gainwidpatience on May 10, 2021 9:21am
Even though IntegraSyn news was positive, we are still trading around $35m market cap. Both Tetra and Willow are having $160m+ mkt cap. Why are we trading so low??
Comment by Stevemin on May 10, 2021 2:28pm
Because there is still no evidence that speaks to the quality - pharma grade - material they can produce. They really only brused a broad stroke over the yield and cost (somewhat). There still was no real "substance" in the news realease (this is a specialty of Adamsas we have al grown accustomed to). At this point, If they can prove the level of grade, then they should divulge it ...more  
Comment by gainwidpatience on May 13, 2021 1:11pm
They never made any attempt to increase investor awareness over these years. There are hardly anyone talking about this company on social media. So, the question is how this stock has 80k average volume everyday and who is controlling the sp. They didn't seem to be bothered about sp being low during the last webinar. It looks like they are very happy with the money in the bank and they can ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities